Black Rock Inc. Ampio Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.08 - $21.0 $4,502 - $1.18 Million	-56,279 Reduced 1.2%	4,642,785 $281,000
Q2 2022 Aug 12, 2022	SELL	$0.16 - $0.47 $1.49 Million - $4.37 Million	-9,297,010 Reduced 66.43%	4,699,064 $789,000
Q1 2022 May 12, 2022	BUY	$0.42 - $0.62 $25,732 - $37,986	61,269 Added 0.44%	13,996,074 $6.58 Million
Q4 2021 Feb 10, 2022	BUY	$0.56 - $1.71 $923,244 - $2.82 Million	1,648,651 Added 13.42%	13,934,805 $7.94 Million
Q3 2021 Nov 09, 2021	BUY	$1.21 - $1.8 $176,028 - $261,860	145,478 Added 1.2%	12,286,154 $20.4 Million
Q2 2021 Aug 11, 2021	BUY	$1.56 - $1.98 $18.9 Million - $24 Million	12,140,676 New	12,140,676 $20.3 Million

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.